April 2022

• NPAC held a Congressional briefing and conducted meetings with Senate HELP and House Energy and Commerce Committees and other key members related to updates to the Centers for Disease Control and Prevention’s prescribing guideline.

• NPAC filed an extensive written comment on the Centers for Disease Control and Prevention’s proposed prescribing guideline.